References
- Caprio FZ, Sorond FA. Cerebrovascular disease: primary and secondary stroke prevention. Med Clin North Am. 2019;103:295–308.
- Dharmakidari S, Bhattacharya P, Chaturvedi S. Carotid artery stenosis: medical therapy, surgery, and stenting. Curr Neurol Neurosci Rep. 2017;17:77.
- Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603.
- Nguyen BM, Lin KW, Mishori R. Public health implications of overscreening for carotid artery stenosis, prediabetes, and thyroid cancer. Public Health Rev. 2018;39:18.
- Sardar P, Chatterjee S, Aronow HD, et al. Carotid artery stenting versus endarterectomy for stroke prevention: a meta-analysis of clinical trials. J Am Coll Cardiol. 2017;69:2266–2275.
- Lamanna A, Maingard J, Barras CD, et al. Carotid artery stenting: current state of evidence and future directions. Acta Neurol Scand. 2019;139:318–333.
- Serra R, Barbetta A, Fugetto F, et al. Emergent treatment of carotid stenosis: an evidence-based systematic review. Minerva Chir. 2018;73:505–511.
- Zhang L, Zhao Z, Ouyang Y, et al. Systematic review and meta-analysis of carotid artery stenting versus endarterectomy for carotid stenosis: a chronological and worldwide study. Medicine (Baltimore). 2015;94:e1060
- Salem MM, Alturki AY, Fusco MR, et al. Carotid artery stenting vs. carotid endarterectomy in the management of carotid artery stenosis: lessons learned from randomized controlled trials. Surg Neurol Int. 2018;9:85.
- Featherstone RL, Dobson J, Ederle J, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): a randomised controlled trial with cost-effectiveness analysis. Health Technol Assess. 2016;20:1–94.
- McCullough PA, Young A, Shutze WP. Acute kidney injury after carotid artery stenting. JACC Cardiovasc Interv. 2015;8:1515–1517.
- Donahue M, Visconti G, Focaccio A, et al. Acute kidney injury in patients with chronic kidney disease undergoing internal carotid artery stent implantation. JACC Cardiovasc Interv. 2015;8:1506–1514.
- Paraskevas KI, Mikhailidis DP. Contrast-induced acute kidney injury in patients undergoing carotid artery stenting: an underestimated issue. Angiology. 2017;68:752–756.
- Bellosta S, Corsini A. Statin drug interactions and related adverse reactions: an update. Expert Opin Drug Saf. 2018;17:25–37.
- Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388:2532–2561.
- Hussain MA, Saposnik G, Raju S, et al. Association between statin use and cardiovascular events after carotid artery revascularization. J Am Heart Assoc. 2018;7:e009745.
- Colussi G, Zuttion F, Bais B, et al. Pre-procedural statin use is associated with improved long-term survival and reduced major cardiovascular events in patients undergoing carotid artery stenting: a retrospective study. J Clin Med 2018;7:286.
- Texakalidis P, Giannopoulos S, Jonnalagadda AK, et al. Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis. J Endovasc Ther. 2018;25:624–631.
- Rizwan M, Faateh M, Dakour-Aridi H, et al. Statins reduce mortality and failure to rescue after carotid artery stenting. J Vasc Surg. 2019;69:112–119.
- Azzalini L, Spagnoli V, Ly HQ. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies. Can J Cardiol. 2016;32:247–255.
- Millar JA. The Cockroft and Gault formula for estimation of creatinine clearance: a friendly deconstruction. N Z Med J. 2012;125:119–122.
- Oliveira PP, Vieira J, Guimaraes RB, et al. Risk-benefit assessment of carotid revascularization. Arq Bras Cardiol. 2018;111:618–625.
- Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120:229–243.
- Matsubara T, Naruse K, Arakawa T, et al. Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study. J Cardiol. 2012;60:389–394.
- Golia E, Limongelli G, Natale F, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16:435
- Mulay SR, Shi C, Ma X, et al. Novel insights into crystal-induced kidney injury. Kidney Dis (Basel). 2018;4:49–57.
- Au TH, Bruckner A, Mohiuddin SM, et al. The prevention of contrast-induced nephropathy. Ann Pharmacother. 2014;48:1332–1342.
- Fu M, Dai W, Ye Y, et al. High dose of atorvastatin for the treatment of contrast-induced nephropathy after carotid artery stenting. Am J Ther. 2017;24:e718–e722.
- Firouzi A, Kazem Moussavi A, Mohebbi A, et al. Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention. J Cardiovasc Thorac Res. 2018;10:149–152.
- Honore PM, Jacobs R, Hendrickx I, et al. Statins and the kidney: friend or foe? Blood Purif. 2017;43:91–96.